Cargando…
What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals
OBJECTIVES: Polypharmacy and multimorbidity are common in long-term care facilities (LTCFs). Reducing polypharmacy may reduce adverse events and maintain quality of life. Deprescribing refers to reducing medications after consideration of therapeutic goals, benefits and risks, and medical ethics. Th...
Autores principales: | Turner, Justin P, Edwards, Susan, Stanners, Melinda, Shakib, Sepehr, Bell, J Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800122/ https://www.ncbi.nlm.nih.gov/pubmed/26966056 http://dx.doi.org/10.1136/bmjopen-2015-009781 |
Ejemplares similares
-
Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study
por: Kua, Chong-Han, et al.
Publicado: (2019) -
Exploration of home care nurse’s experiences in deprescribing of medications: a qualitative descriptive study
por: Sun, Winnie, et al.
Publicado: (2019) -
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017) -
Deprescribing tool for use in older Australians with life-limiting illnesses and limited life expectancy: a modified-Delphi study protocol
por: Shrestha, Shakti, et al.
Publicado: (2021) -
A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial
por: Martin, Philippe, et al.
Publicado: (2017)